Fidelity International’s GenMark Diagnostics, Inc GNMK Stock Holding History

Fidelity International’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-438,785	Closed	-$4.22M	–	536
2017 Q3	$4.22M	Hold	438,785	–	–	0.01%	409
2017 Q2	$5.19M	Hold	438,785	–	–	0.02%	393
2017 Q1	$5.63M	Hold	438,785	–	–	0.02%	399
2016 Q4	$5.37M	Hold	438,785	–	–	0.02%	390
2016 Q3	$5.18M	Hold	438,785	–	–	0.02%	389
2016 Q2	$3.82M	Hold	438,785	–	–	0.01%	405
2016 Q1	$2.31M	Hold	438,785	–	–	0.01%	425
2015 Q4	$3.4M	Hold	438,785	–	–	0.01%	400
2015 Q3	$3.45M	Buy	438,785 +53,266	+14%	+$493K	0.01%	410
2015 Q2	$3.49M	Buy	385,519 +80,173	+26%	+$809K	0.01%	445
2015 Q1	$3.96M	Buy	+305,346	New	+$3.99M	0.01%	425

Other funds holding GNMK

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity International's GNMK Position: Q4 2017 in Review

Fidelity International sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2017, closing a stake of 438,785 shares — an estimated $4.22M sold.

Fidelity International first reported a position in GNMK in Q1 2015 and held it in 11 quarters. The position peaked at $5.63M in Q1 2017. 99 funds tracked by Wall St. Rank hold GNMK as of Q4 2017.

Fidelity International reported no remaining GenMark Diagnostics, Inc position as of Q4 2017 after selling out during the quarter.
Fidelity International sold 438,785 GenMark Diagnostics, Inc shares in Q4 2017, an estimated $4.22M.
Fidelity International first reported a position in GenMark Diagnostics, Inc in Q1 2015 and held it in 11 quarters.
Fidelity International's GenMark Diagnostics, Inc position peaked at $5.63M in Q1 2017.
99 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2017.

Based on Fidelity International's 13F filing for Q4 2017, filed 12 Feb 2018.